In 17 fetal sheep aged 129 days, the effects of large dose infusions of cortisol (72.1 mg.day -1 for 2-3 days) on proliferation, binucleation and hypertrophy of cardiac myocytes, cardiac expression of angiotensinogen, angiotensin receptor subtypes 1 and 2, Glut-1, glucocorticoid and mineralocorticoid receptors, proteins of the mitogen activated kinase (MAPK) pathways and calcineurin were studied.
Introduction
Before birth the right ventricle is the major cardiac pump in terms of output and the resistances to flow from right and left ventricles are similar. After birth right ventricular output is ejected into the low resistance pulmonary circuit, while left ventricular output is ejected into the much higher resistance of the systemic vasculature.
By 4 days after birth, the right ventricular free wall (RVFW) mass of the lamb is reduced by nearly 50% (relative to the mass measured at 145-146 days gestation). At 4-6 weeks of age the numbers of myocytes in both left ventricular (LVFW) and RVFWs are less than the numbers found in the fetus at 145-146 days gestation (term approx. 150 days, 5).
Cortisol is a key fetal hormone that affects cellular and organ differentiation (8) . High levels of cortisol occur as a result of labor and synthetic steroids are used in the treatment of premature labor. Cortisol was hypertensinogenic in fetal sheep (33) and caused a reduction in fetal sheep cardiac DNA levels (25). Prenatal dexamethasone also increased the protein:DNA ratio in neonatal rat hearts (29). We postulated that high levels of cortisol would affect the rate of binucleation of fetal cardiac myocytes and/or their size and number.
Since there is extensive remodeling of the heart at birth, we also proposed that these effects of cortisol might be associated with altered expression of cardiac genes known to be associated in the adult with cardiac remodeling (i.e. genes of the cardiac renin angiotensin system (RAS), and genes for the cardiac glucocorticoid and mineralocorticoid receptor). Lindpainter et al (19) have shown that pretreatment with dexamethasone stimulated angiotensinogen (Aogen) gene expression and efflux of Aogen from the adult rat heart. Angiotensin II (Ang II) is known to cause cardiac hypertrophy and the signaling cascades known to be associated with myocyte growth and hypertrophy, i.e. the mitogen activated protein kinase (MAPK) cascades and calcineurin may be involved. In isolated fetal sheep myocytes, insulin-like growth factor-I (IGF-I) and angiotensin II stimulate extracellular signal regulated kinases (ERKs) along with cellular proliferation, suggesting the ERK cascade is active in fetal heart (30, 31). As we were examining the effects of cortisol on the cardiac RAS we also looked at the effects of large dose infusions of cortisol on levels of components of ERK 1/2, the c-Jun N-terminal kinase (JNK) and p38 MAPK cascades and calcineurin.
Glut-1 is the major glucose transporter in the fetal rat heart. At birth it is suppressed and in the adult Glut-4 becomes the major glucose transporter (27) . Thyroid hormones control this switching in the perinatal period (7) . Since cortisol like the thyroid hormones is involved in development we thought it might also affect the level of expression of Glut-1.
Binucleated myocytes are terminally differentiated and cannot undergo cellular division (11, 18) . Thus, at a given age of development, the proportion of cardiac myocytes that are uninucleated indicates the capacity of the developing heart to grow by hyperplasia. Up to 110 days gestation the fetal sheep heart grows mainly by hyperplasia; after this time ventricular free wall (VFW) mass increases by both hypertrophy and hyperplasia (5) .
By 145-146 days gestation most fetal sheep cardiac myocytes are binucleated (5).
Therefore, the capacity of the sheep heart to grow by hyperplasia after birth, is limited. In the pig, however, 90% of cardiac myocytes are mononuclear at birth (2) and after birth there is no loss of myocytes from the RVFW; LVFW myocyte numbers increase by 28% (2). However, in nearly all mammalian species, the developing heart ceases to grow by hyperplasia before or shortly after birth. Thus factors that alter the rate of terminal differentiation of cardiac myocytes could influence the number of myocytes present in the adult heart. Studies in the neonatal pig have shown that normal cardiac development depends on the integrity of the neonatal RAS (2, 3). From these experiments it was not possible to determine if blockade of the neonatal RAS simply reduced after-load and this led to underdevelopment of the heart or if angiotensin played a role in cardiac myocyte development. However, blockade of the rat RAS for the first week of life decreased the number of proliferating myocytes by 23% (9) .
Methods
The Animal Care and Ethics Committee of the University of New South Wales approved these experiments. 17 fetuses from 16 crossbred Merino ewes were studied. Ewes were moved from holding pens to metabolic cages up to 1 week before the study was performed, and given free access to 1.2 kg lucerne chaff, 300 g oats and 6 L water each day. Food and fluid intake, and urine production were measured daily to monitor the health of the ewe. Laboratories) were given intramuscularly to the ewe, and to the fetus via the amniotic catheter. On the third day following surgery, all ewes were given i.m. 150 mg medroxyprogesterone acetate (Depo-Provera, Upjohn, Rydalmere, NSW, Australia) to prolong the time before ewes went into labor.
Experimental protocol
Experiments began 5 or more days after surgery when maternal food and fluid intake had returned to preoperative levels. Fetuses were 128-130 days old when the experiments finished. Fetuses were given either hydrocortisone sodium succinate (Solu-Cortef, Pharmacia & Upjohn, Rydalmere, NSW, Australia, 72.1 mg.day -1 , n = 9) in 0.15M saline or 0.15M saline alone (n = 8) at an i.v. infusion rate of 0.66 ml.h -1 for 2-3 days. Infusions were stopped at 72h or earlier (mean time 61 ± 3.5h, SE) if ewes showed behavioral or physical signs of going into labor.
Fetal arterial blood samples (5ml) were collected into heparinized syringes 15 min before the infusions began, at 1h, 48h and immediately before sacrifice (56-72h).
Arterial PO 2 and pH corrected to 39.5°C were measured immediately using a blood gas analyzer (ABL-715, Radiometer, Copenhagen). Hematocrit was measured using a Hettich centrifuge. The remaining blood was centrifuged at 1100 g for 10 min at 4°C, and the plasma stored at -20°C. Plasma cortisol was measured using a coated tube radioimmunoassay (Spectria, Orion Diagnostica, Espoo, Finland) after separation from cortisol binding proteins using a dichloromethane extraction process (4).
Fetal arterial and amniotic pressures and heart rate were measured in 5 fetuses (3 cortisol infused and 2 saline infused) using disposable transducers (Biotrans 11 dome, Critical Assist Group, Sydney, Australia) connected to a Grass Polygraph recorder (Model 79E). Measurements were made for 1 h on the final day of the study, approximately 2 -3 h before the animals were sacrificed. Heart rate was determined from the beat to beat interval, and blood pressure was corrected for amniotic pressure. 
Preparation of cardiac myocytes
The small blocks of myocardium (~1 cm 3 , extending from the epicardium to the endocardium) were sliced (Vibroslicer 752, Campden Instruments Ltd, speed 9) into 400 µm thick sections and myocytes were isolated using a method already described (5 
Real time PCR
Real time PCR was used to measure expression of Aogen, AT 1 and AT 2 receptors, Glut-1, glucocorticoid receptor (GR), mineralocorticoid receptor (MR) mRNAs and the endogenous reference, 18S rRNA in both VFWs. Total RNA was extracted from 0.4-0.6 g of VFW using a modified acid-guanidinium phenol chloroform method (10).
The extracted total RNA was treated with DNase, then reverse transcribed using a TaqMan Reverse Transcription Reagents kit (Applied Biosystems) and methods described previously (12). To assess genomic contamination of cDNA, control reactions with no reverse transcriptase were included in a separate reverse transcription reaction for all samples.
Real time PCR reactions were carried out using an ABI PRISM 7700 Sequence
Detector (Applied Biosystems) in 25 µl containing either 5 ng or 50 ng of cDNA.
Primers and probes were designed using Primer Express Version 1.0 (Applied Biosystems, Table 1 ), and their sequences and preliminary experiments to determine appropriate concentrations and optimal conditions for use are described elsewhere (12). Reactions were multiplexed with the target gene and 18S gene expression detected in each well, and primers limited for 18S.
Relative quantitation of target cDNA sequences was carried out using the multiplex comparative C T method. Levels of mRNA or 18S rRNA in each sample were expressed relative to their levels in a "calibrator" sample from the right ventricle of a fetus from the saline infused group. For comparative C T calculations, 18S C T values were subtracted from target gene C T values for each well to give a C T value for each unknown and calibrator sample. The average calibrator C T was subtracted from each unknown C T ( C T ), and finally the cardiac expression of the genes studied, relative to 18S, and relative to the calibrator sample, was evaluated using the expression 2 C T . The intra assay coefficients of variation for the mRNAs studied were: Aogen (Table 2) The mean length of infusions was 61 ± 3.5h. The 9 cortisol treated fetuses were either 128 (n=4) or 129 (n=5) days old and the untreated fetuses were 128 (n=3), 129 (n=3) and 130 (n=2) days old at time of sacrifice and final blood and tissue collection.
Results

Fetal plasma cortisol levels
Plasma cortisol levels were measured in all fetuses during control, after 1h and 48h of either cortisol or saline infusion, and in some fetuses at 72h. By 48h, plasma cortisol values were markedly elevated in cortisol infused fetuses and unchanged from control values in saline infused fetuses.
Fetal growth (Table 3)
Fetal body weight (FBW) was inversely related to plasma cortisol levels (r= 0.49, n=17, P<0.05). Treated and untreated fetuses had similar weights for heart, ventricular free wall (VFW) interventricular septum, liver, lungs and kidneys. LVFW weight was greater than the weight of the RVFW in both groups (cortisol P<0.001; saline P<0.005).
In cortisol treated fetuses the ratios of heart weight:FBW (P<0.05), RVFW weight:FBW (P<0.03), LVFW weight:FBW (P<0.05) and liver weight:FBW (P<0.002) were greater than these ratios in saline infused fetuses. There were positive relationships between plasma cortisol levels and the ratios of heart weight:FBW (r=0.65, n=17, P<0.005); RVFW weight : FBW (r=0.52, n=17, P<0.04) and of LVFW weight:body weight (r=0.54, n=17, P<0.03).
Fetal blood pressure, heart rate and blood gases (Table 4) In 5 fetuses (3 cortisol and 2 saline infused) arterial pressure was measured to confirm our previous findings (15, 33 ) that cortisol causes a rise in fetal arterial pressure.
Blood pressure was increased in cortisol infused fetuses compared with saline infused fetuses (P<0.05, Table 4 ). At the end of the infusion, systolic blood pressure was positively related to plasma cortisol concentration (r=0.9, n=5, P<0.04). There was no difference in fetal heart rate between the two groups.
Fetal arterial pH was similar in the two groups and did not change. Prior to treatment cortisol treated fetuses had lower arterial PO 2 levels than saline infused fetuses (P<0.05), but by the end of treatment levels were similar in the two groups and higher than control values in cortisol group (P<0.05). Cortisol treated fetuses had a higher hematocrit before treatment but this was not significantly different from that of saline infused fetuses. However the further small, non-significant rise in haematocrit during cortisol infusion meant that by the end of the experiment, haematocrit levels were greater in the cortisol treated group (P<0.05).
Cardiac myocyte volume and number of nuclei
As expected at this stage of gestation in the fetal sheep, approximately half of the cardiac myocytes examined were uninucleated (57 ± 4% in RVFW and 54 ± 3% in the LVFW of saline infused fetuses). The proportions of RVFW or LVFW myocytes that were uninucleated (53 ± 2% in RVFW and 54 ± 4% in LVFW) were no different in cortisol treated fetuses from the proportions measured in untreated fetuses.
In saline infused fetal sheep, multinucleated cardiac myocytes were larger than 
Effects of cortisol on the expression of components of fetal cardiac renin angiotensin system and other cardiac genes (Table 5)
In both groups, levels of Aogen, AT 1 , AT 2 , Glut-1, GR and MR mRNA were similar in the RVFW and LVFW (Table 5 ). RVFW and LVFW Aogen mRNA levels were both increased in cortisol infused fetal sheep (P<0.02, Table 5 ). There were positive correlations between LVFW and RVFW Aogen mRNA levels and the last measured plasma cortisol level (r=0.83, n=14, P=0.0003 and r=0.61, n=16, P<0.02 respectively, Figure 3 ). Neither cardiac AT 1 nor AT 2 receptor mRNA levels were changed in cortisol treated fetuses.
LVFW Glut-1 mRNA levels were lower in the cortisol treated group (P<0.05, Table   5 ); the lower levels of Glut-1 in the RVFW in cortisol treated fetuses were not significantly different from values obtained in saline-infused fetuses.
Immunoblotting of hypertrophic signaling proteins.
Expression of myocardial total and phosphorylated (activated) ERK1/2, JNK, P38, as well as calcineurin were similar in cortisol treated and saline infused fetal sheep ( Figure 4 ).
Discussion
Birth is associated with extensive remodelling of the heart. In the fetal sheep there is marked hypertrophy of cardiac myocytes and a reduction in myocyte number within 4 days of birth (5) . In other species, the RAS plays a role in neonatal cardiac development (2, 3). Our aim was to find out if high levels of cortisol affected myocyte binucleation, size and number and if cortisol affected the expression of cardiac genes associated with myocardial growth. The doses of cortisol used produced plasma levels similar to those occurring following labour and delivery. Their effects would be similar to those seen with doses of synthetic steroids used in the management of preterm labour.
Cortisol did not affect the rate at which myocytes became terminally differentiated as proportion of RVFW and LVFW cardiac myocytes that were binucleated was similar in the two groups of fetuses and similar to others of the same gestational age reported in our previous study (5).
As expected, both RVFW uni-and binucleated cardiac myocytes were larger than LVFW myocytes and binucleated myocytes were about 40-50% larger than uninucleated myocytes (Figure 2 Cortisol treated fetuses had bigger heart weights relative to body weights and the ratios of the masses of RVFW and LVFWs to body weight were greater ( Table 3 ). The increase in these cardiac to body weight ratios appeared to be related to plasma cortisol levels. Also, there were no changes in the estimated number of myocytes in receptor subtype, the function of which is largely unknown (6) . AT 1 receptors are present in the ventricular myocardium but their density is much lower. The density of cardiac AT 2 receptors declines with increasing gestation (6) . In younger fetal sheep (118 days) low doses of cortisol (29 ± 4 nM) had no effect on the density of aortic, carotid and RVFW AT 1 and AT 2 receptors (15) . RVFW and LVFW receptor densities were similar (6) but the response of fetal LVFW AT 1 and AT 2 receptors to low dose cortisol was not studied. Since high doses of cortisol had no effect on the mRNA levels of either RVFW or LVFW AT 1 and AT 2 receptors the perinatal fall in cardiac Ang II receptors (28) and in AT 2 receptor mRNA levels (26), does not depend on the high levels of cortisol occurring as a result of parturition.
Glucose is a major source of energy for cardiac muscle and Glut-1 is the major glucose transporter in the cardiac myocytes of the fetal rat. In the adult rat, Glut-4 becomes the major transporter (27). Santalucia et al (27) suggest that Sp1 is the major transcriptional factor promoting Glut-1 expression during fetal life and that it is downregulated during neonatal life. In myoblasts, products of Sp3 transcription inhibit Glut-1 expression (14) . There is no evidence linking regulation of Sp1, Sp3 or Glut-1 expression to cortisol, although it has been shown that thyroidectomy prevents the neonatal repression of Glut-1 expression (7), suggesting that these transcription factors controlling Glut-1 expression may be regulated by hormones. Our finding that Glut-1 mRNA levels were significantly reduced in the LVFW and lower in the RVFW of cortisol treated fetal sheep may indicate that high levels of cortisol in the perinatal period also modulate Glut-1 expression in the heart at birth.
We also examined the expression of GR and MR. There is strong evidence that mineralocorticoids influence cardiac remodelling and fibrosis of the adult heart, which has led to a revival of the use of aldosterone antagonists and development of new antagonists for the treatment of congestive cardiac failure (35). However we found that high doses of cortisol did not affect mRNA levels of either GR or MR.
The three MAPK cascades were studied (Figure 4 ). The lack of myocardial ERK, JNK and P38 activation in the present study is perhaps not surprising as we found no evidence MAPK activity possibly by inhibiting phosphorylation or by upregulating the MAPK phosphatases (which in turn dephosphorylates ERK, JNK and P38; 13, 24).
Calcineurin mediated translocation of NFAT transcription factors is a central regulator of cardiac hypertrophic growth. In cell lines, dexamethasone rapidly increases calcineurin activity through activation of IP3-dependent calcium stores (34). In rats, mineralocorticoid induced cardiac hypertrophy is associated with increased myocardial calcineurin activity (32). We initially postulated that cortisol, which exerts both mineralocorticoid and glucocorticoid activities, would be associated with increased calcineurin levels. However, our data fail to support this. Interestingly, myocardial calcineurin levels were not altered in pressure and volume overload models of fetal cardiac hypertrophy (unpublished observations), suggesting calcineurin may have little role in the heart until postnatal life.
In summary, high doses of cortisol such as might occur in early postnatal life do not alter the rate of terminal differentiation of cardiac myocytes nor affect their number.
There is evidence of a hypertrophic effect of cortisol on LVFW myocytes. Cardiac
Aogen mRNA levels were increased in cortisol treated animals and Glut-1 levels were depressed. The potential effects of increased levels of Aogen in the fetal sheep heart are unknown. Our findings also suggest that cortisol may play a role in neonatal suppression of Glut-1 gene expression. Angiotensin receptors in the rat myocardium during pre-and postnatal development. Numbers in parentheses are the number of fetuses studied if the number is less than the total number in the group. ***P<0.001 compared to control values. Lung weight (g) 79.8 ± 7.7 91.5 ± 8.1 (6) Combined kidney weight (g) 23.4 ± 1.8 24.9 ± 0.9
Heart:body weight 0.74 ± 0.02 * 0.68 ± 0.02 RVFW:body weight 0.16 ± 0.01 * 0.14 ± 0.01 LVFW:body weight 0.19 ± 0.01 * 0.17 ± 0.01
Liver:body weight 3.48 ± 0.16 *** 2.62 ± 0.11 (7) Values are means ± SE. RVFW and LVFW, right and left ventricular free wall, IVS, interventricular septum. * P<0.05, *** P<0.001. Number of animals is shown in parentheses. 
